<SEC-DOCUMENT>0000744825-21-000052.txt : 20210513
<SEC-HEADER>0000744825-21-000052.hdr.sgml : 20210513
<ACCEPTANCE-DATETIME>20210513114036
ACCESSION NUMBER:		0000744825-21-000052
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20210513
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210513
DATE AS OF CHANGE:		20210513

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMERICAN SHARED HOSPITAL SERVICES
		CENTRAL INDEX KEY:			0000744825
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				942918118
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08789
		FILM NUMBER:		21918000

	BUSINESS ADDRESS:	
		STREET 1:		2 EMBARCADERO CENTER
		STREET 2:		SUITE 410
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111
		BUSINESS PHONE:		415-788-5300

	MAIL ADDRESS:	
		STREET 1:		2 EMBARCADERO CENTER
		STREET 2:		SUITE 410
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ashs-8xkitemnos2029011q2021.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i66051295db4646849b055060f8831a09_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;</font></div><div style="margin-bottom:9.75pt;padding-left:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:167%">&#160;</font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:167%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:132%">UNITED STATES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:167%">&#160;</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:93%">FORM 8-K</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:139%">CURRENT REPORT </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.784%"><tr><td style="width:1.0%"></td><td style="width:31.061%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.821%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of report (Date of earliest event reported)&#58; May 13, 2021</font></td></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">AMERICAN SHARED HOSPITAL SERVICES</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Exact name of registrant <br>as specified in charter)</font></td></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">California</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1-08789</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">94-2918118</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(State or other jurisdiction of incorporation)</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Commission File Number)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(IRS Employer Identification No.)</font></td></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Two Embarcadero Center, Suite 410</font></div><div style="margin-bottom:1.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">San Francisco, CA</font></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">94111</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of principal executive offices)</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Zip Code)</font></td></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:3.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">Registrant&#8217;s telephone number, including area code </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">415-788-5300</font></div></td></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</font></td></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:167%">Securities registered pursuant to Section 12(b) of the Act&#58;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.784%"><tr><td style="width:1.0%"></td><td style="width:31.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.821%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title of each class</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trading Symbol(s)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name of each exchange on which <br>registered</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">American Shared Hospital Services Common Stock, No Par Value</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMS</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NYSE AMERICAN</font></td></tr></table></div><div style="margin-bottom:6pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions&#58;</font></div><div style="margin-bottom:9.75pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:167%">&#91; &#93; Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div><div style="margin-bottom:9.75pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:167%">&#91; &#93; Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div><div style="margin-bottom:9.75pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:167%">&#91; &#93; Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div><div style="margin-bottom:9.75pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:167%">&#91; &#93; Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:167%">&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:176%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (</font><font style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:176%">&#167;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:176%">230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (</font><font style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:176%">&#167;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:176%">240.12b-2 of this chapter).</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:209%">&#160;</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:167%">&#91; &#93; Emerging growth company</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:167%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:167%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  &#91; &#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:167%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:167%">Item 2.02 Results of Operations and Financial Condition.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:167%">On May 13, 2021 the Company issued a press release announcing its financial results for the first quarter 2021. The full text of the press release is furnished as Exhibit&#160;99.1 to this report. The Company does not intend for this exhibit to be incorporated by reference into future filings under the Securities Exchange Act of 1934.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:167%"> </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:167%">Item 9.01 Financial Statements and Exhibits.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:167%">(d) Exhibits.</font></div><div style="margin-top:12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:167%;text-decoration:underline"><a href="amsq12021earningsreleasefi.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:167%;text-decoration:underline">Exhibit 99.1</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:167%"> &#8212; Earnings Press Release dated May 13, 2021</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:167%">The information in this report is summary information that is intended to be considered in the context of our SEC filings and other public announcements that we may make, by press release or otherwise, from time to time. We disclaim any current intention to revise or update the information contained in this report, although we may do so from time to time as our management believes is warranted. Any such updating may be made through the filing of other documents or reports with the SEC, through press releases or through other public disclosures.</font></div><div style="margin-bottom:9.75pt;margin-top:9.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:167%">SIGNATURES</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.958%"><tr><td style="width:1.0%"></td><td style="width:7.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">American Shared Hospital Services</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 13, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47;Raymond C. Stachowiak</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raymond C. Stachowiak</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer</font></td></tr></table><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>amsq12021earningsreleasefi.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ib781c5558d58404d89469ab9ea7de6a2_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:125%">American Shared Hospital Services Reports First Quarter 2021 Financial Results</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">Company Reports Breakeven Results on Revenue of &#126;$4.4 Million</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">SAN FRANCISCO, CA, May 13, 2021-- American Shared Hospital Services (NYSE American&#58; AMS) (the &#34;Company&#34;), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced financial results for the first quarter of fiscal 2021 ended March 31, 2021.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">First Quarter Financial Highlights </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Total revenue in the first quarter was $4,364,000, a decrease of 4.5% when compared with the first quarter of 2020.&#160;Proton therapy revenue was $1,531,000, a decrease of 8.7% when compared with the first quarter of 2020. Gamma Knife revenue of $2,892,000 was even with revenue in the first quarter of 2020. </font></div><div><font><br></font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.5pt">Total proton therapy fractions decreased 26.6% compared to the first quarter of 2020.&#160;</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.5pt">Gamma Knife procedures decreased by 5.6% to 355 for the first quarter of 2021. Gamma Knife volumes for centers in operation were even with Gamma Knife volumes for those same centers during the same period of the prior year.</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.5pt">Operating income for the first quarter of 2021 was $90,000 compared to an operating loss of $99,000 in the first quarter of 2020.</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.5pt">Net income in the first quarter was $29,000, or $0.00 per diluted share, compared to a net loss of $135,000, or $(0.02) per diluted share, for the first quarter of 2020.  </font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8220;AMS had a good start to the 2021 year, reporting breakeven results on approximately $4.4 million in revenue in the first quarter,&#8221; said Ray Stachowiak, Chief Executive Officer of AMS. &#8220;Our financial results have begun to reflect the impact of the year end asset write-downs and the financial restructuring with Fifth Third Bank that we announced in early April. Most significantly, we strengthened our balance sheet and swung to positive working capital of $4.2 million compared to negative $1.5 million as of December 31, 2020.  In addition, we are reducing our principal debt payment obligations over the next twelve months by approximately $5.9 million, expect to realize over $0.35 million in interest expense savings, and free up $0.3 million in previously restricted cash. This is in addition to our focus on reducing selling and administrative expenses, which decreased 10.5% in the first quarter. The refinancing also provides us with ample funds to accelerate the growth of our business, which we&#8217;re actively pursuing with the expanded radiation therapy equipment offerings that we&#8217;ve previously discussed. </font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In the first quarter, total revenue declined 4.5% compared to the same period last year, the only mostly non-pandemic impacted quarter of the 2020 year. Gamma Knife revenue rebounded from the pandemic lows and was even with a strong quarter last year, with higher reimbursement in the current first quarter offsetting a 5.6% decline in procedures. Our Gamma Knife Centers in Peru and Ecuador both had a strong first quarter despite the COVID-19 challenges in those countries. COVID-19 is having a lingering impact on PBRT volumes, and combined with planned maintenance, fractions were down 26.6% in the quarter. PBRT revenue was down 8.7% offset by higher average reimbursement per fraction. Assuming that the pandemic continues to recede, we expect patient volumes to normalize,&#8221; concluded Mr. Stachowiak.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Financial Results for the Three Months Ended March 31, 2021</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">For the three months ended March 31, 2021, total revenue was $4,364,000, a decrease of 4.5% when compared with $4,568,000 reported for the first quarter of 2020.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">First quarter revenue for the Company's proton therapy system installed at Orlando Health in Florida was $1,531,000, a decrease of 8.7% when compared with the first quarter of 2020. Higher average reimbursement per fraction was offset by lower number of fractions period-over-period. Total proton therapy fractions decreased 26.6% to 1,231 for the three-month period ended March 31, 2021 compared to 1,676 for the same period in the prior year. The period-over-period decrease was primarily due to the continued impact from COVID-19 compounded by maintenance-related downtime.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Revenue for the Company's Gamma Knife operations was $2,892,000, even compared with the first quarter of 2020. A decrease in first quarter 2021 volume was offset by an increase in average reimbursement. Gamma Knife procedures decreased by 5.6% to 355 for the first quarter of 2021 from 376 in the same period of the prior year. The decrease was primarily due to the expiration of a contract in the fourth quarter of 2020 and a contract in the first quarter of 2021, offset by the acquisition of GKCE in the second quarter of 2020.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:125%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Gamma Knife volumes for centers in operation were even with Gamma Knife volumes for those same centers during the same period of the prior year.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Gross margin for the first quarter of 2021 increased to $1,434,000, or 32.9% of revenue, compared to gross margin of $1,394,000, or 30.5% of revenue, for the first quarter of 2020. </font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Selling and administrative costs decreased to $1,084,000 for the first quarter, a 10.5% decrease compared to $1,211,000 for the first quarter of 2020. The period-over-period decrease is due to lower legal and other fees. </font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Operating income for the first quarter of 2021 was $90,000 compared to an operating loss of $99,000 in the first quarter of 2020.  </font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Net income for the first quarter of 2021 was $29,000, or $0.00 per diluted share.&#160; This compares to a net loss for the first quarter of 2020 of $135,000, or $(0.02) per diluted share.&#160;Weighted average diluted common shares were 6,322,000 and 6,153,000 for the first quarter of 2021 and 2020, respectively. The $164,000 positive swing in net income for the three-month period ended March 31, 2021 was due to a decrease in depreciation expense and selling and administrative costs.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Adjusted EBITDA, a non-GAAP financial measure, was $1,600,000 for the first quarter of 2021, compared to $1,822,000 for the first quarter of 2020. </font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Balance Sheet Highlights </font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">At March 31, 2021, cash, cash equivalents, and restricted cash was $5,013,000 compared to         $4,325,000 at December 31, 2020.&#160; Shareholders' equity at March 31, 2021 was $23,844,000, or $4.11 per outstanding share.&#160; This compares to shareholders' equity at December 31, 2020 of $23,650,000, or $4.08 per outstanding share.</font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Conference Call and Webcast Information </font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">AMS has scheduled a conference call at 10&#58;00 a.m. PT (1&#58;00 p.m. ET) today. To participate, please call 1 (877) 317-6789 at least 10 minutes prior to the start of the call and ask to join the American Shared Hospital Services call. A simultaneous Webcast of the call may be accessed through the Company's website, www.ashs.com, or at www.streetevents.com for institutional investors.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">A replay of the call will be available at 1 (877) 344-7529, access code 10156388, through May 20, 2021. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">About American Shared Hospital Services (NYSE American&#58; AMS)</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">American Shared Hospital Services is a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services.&#160;AMS is a world leader in providing Gamma Knife radiosurgery equipment, a non-invasive treatment for malignant and benign brain tumors, vascular malformations, and trigeminal neuralgia (facial pain).&#160;The Company also offers proton therapy, and the latest IGRT, IMRT and MR&#47;LINAC systems. For more information, please visit&#58;&#160;</font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">www.ashs.com&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Safe Harbor Statement</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">This press release may be deemed to contain certain forward-looking statements with respect to the financial condition, results of operations and future plans of American Shared Hospital Services (including statements regarding the expected continued growth of the Company and the expansion of the Company&#8217;s Gamma Knife, proton therapy and MR&#47;LINAC business, which involve risks and uncertainties including, but not limited to, the risks of economic and market conditions, the risks of variability of financial results between quarters, the risks of the Gamma Knife and proton therapy businesses, the risks of developing The Operating Room for the 21st&#160;Century program, the risks of changes to CMS reimbursement rates or reimbursement methodology, the risks of the timing, financing, and operations of the Company&#8217;s Gamma Knife, proton therapy, and MR&#47;LINAC businesses, the risks of the COVID-19 pandemic and its effect on the Company&#8217;s business operations and financial condition, the risk of expanding within or into new markets, the risk that the integration or continued operation of acquired businesses could adversely affect financial results and the risk that current and future acquisitions may negatively affect the Company&#8217;s financial position. Further information on potential factors that could affect the financial condition, results of operations and future plans of American Shared Hospital Services is included in the filings of the Company with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for the year ended December 31, 2019, and the definitive Proxy Statement for the Annual Meeting of Shareholders to be held on June 25, 2021.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Non-GAAP Financial Measure</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Adjusted EBITDA, the non-GAAP measure presented in this press release and supplementary information, is not a measure of performance under the accounting principles generally accepted in the United States (&#34;GAAP&#34;).&#160; This non-GAAP financial measure has limitations as an analytical tool, including that it does not have a standardized meaning. When assessing our operating performance, this non-GAAP financial measure should not be considered a substitute for, and investors should also consider, income (loss) before income taxes, income (loss) from operations, net income (loss) attributable to the Company, earnings (loss) per share and other measures of performance as defined by GAAP as indicators of the Company's performance or profitability.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Adjusted EBITDA is a non-GAAP financial measure representing our (loss) earnings before interest, taxes, depreciation, and amortization. We define Adjusted EBITDA as net (loss) income before interest expense, income tax (benefit) expense, depreciation and amortization expense, and stock-based compensation expense. </font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">We use this non-GAAP financial measure as a means to evaluate period-to-period comparisons. Our management believes that this non-GAAP financial measure provides meaningful supplemental information regarding our performance by excluding certain expenses and charges that may not be indicative of the operating results of our recurring core business, such as stock-based compensation expense.&#160; We believe that both management and investors benefit from referring to this non-GAAP financial measure in assessing our performance.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Contacts&#58;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">American Shared Hospital Services<br>Ray Stachowiak<br>Chief Executive Officer<br></font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">rstachowiak&#64;ashs.com</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Investor Relations<br>PCG Advisory<br>Stephanie Prince<br>P&#58; (646) 863-6341<br></font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">sprince&#64;pcgadvisory.com</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><img alt="capture1a.jpg" src="capture1a.jpg" style="height:268px;margin-bottom:5pt;vertical-align:text-bottom;width:477px"></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt"><img alt="image_11a.jpg" src="image_11a.jpg" style="height:608px;margin-bottom:5pt;vertical-align:text-bottom;width:614px"></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>capture1a.jpg
<TEXT>
begin 644 capture1a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#R17AI9@  34T *@    @ ! $[  (
M   -   (2H=I  0    !   (6)R=  $    :   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)R860@4F]B
M97)T<P    60 P "    %   $*:0!  "    %   $+J2D0 "     S<R  "2
MD@ "     S<R  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M_8[;_GWB_P"^!1]CMO\ GWB_[X%<N-1U._\ &VJ6B:NNG6>E368\OR49;@2
MED);D,Q*J"#^!)S6=::_XCO=<N);<L;2VUTV,JMY"6ZP A.K$2F7+ C!P2<
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MC/V:7/EOQE>>5]ZMU"W_ !_1?]<W_FM !Y\G_/K+^:?_ !5'GR?\^LOYI_\
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M@V>BW0QY4%H))H RQ1B([I"),9)#XV^@R!5NVTVZM?$]K?:)H$ND6:6\HOX
M8$%W@9B541RN\,3\QV\9&['%=7Y$G_/U+^2?_$T>1)_S]2_DG_Q- ',^$K?4
M],_MO[=I%U%]JO[B^A_>0MN5MNU.).'.#U^7WH\)6^IZ9_;?V[2+J+[5?W%]
M#^\A;<K;=J<2<.<'K\OO73>1)_S]2_DG_P 31Y$G_/U+^2?_ !- ''Z''XAT
MFVUE(-!E^TZAJ<UU;O//#Y4:R%0#)M<MQ@DA0<XP#SFI4\/76EZ;HGA^P6^>
MSM)/.FOX3!]_+$ I(>@9M_W6V[%QEN5ZOR)/^?J7\D_^)H\B3_GZE_)/_B:
M.7T/2M7T3QMJ2A)[K2+]5E:YD\E-LX')VHPX;D%@@).W/ W'KJA\B3_GZE_)
M/_B:/(D_Y^I?R3_XF@":BH?(D_Y^I?R3_P")H\B3_GZE_)/_ (F@":BH?(D_
MY^I?R3_XFCR)/^?J7\D_^)H FHJ'R)/^?J7\D_\ B:/(D_Y^I?R3_P")H FH
MJ'R)/^?J7\D_^)H\B3_GZE_)/_B: )J*A\B3_GZE_)/_ (FCR)/^?J7\D_\
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MV*RM;FBE\CRI$?&[.U@<=* -6S_X\8/^N:_RJ:H;/_CQ@_ZYK_*IJ "BBB@
MJ&S_ ./&#_KFO\JFJ&S_ ./&#_KFO\J )J*** "BBB@ HHHH *KR622:A#>&
M68/"C($64A&#8Y9>A/'![58HI6N5&3CJ@HHHIDA1110 4444 %%%% !1110
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M]^C_ /%4;;G_ )[1?]^C_P#%5-10!#MN?^>T7_?H_P#Q5&VY_P">T7_?H_\
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M_7-_YK0 ?;+;_GXB_P"^Q1]LMO\ GXB_[[%344 0_;+;_GXB_P"^Q1]LMO\
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M=^3OW^7YB!]N[ SC.,X%5M>\3Q^']\EQIFH7%I;PFYO;R"-/*M(AG+L792^
MK$K&'<!>5^9-P!J_;+;_ )^(O^^Q1]LMO^?B+_OL53DUVUC\50: 8[C[7/92
M7JR>21%L1T0C>>"V9!\HR0.3C*[M*@"'[9;?\_$7_?8K*UN:*7R/*D1\;L[6
M!QTK;K'U_P#Y=_\ @7]* -*S_P"/&#_KFO\ *IJJ6JW'V.';+$!Y:X!C)[?[
MU2[;G_GM%_WZ/_Q5 $U%0[;G_GM%_P!^C_\ %4;;G_GM%_WZ/_Q5 $U0V?\
MQXP?]<U_E1MN?^>T7_?H_P#Q516JW'V.';+$!Y:X!C)[?[U %NBH=MS_ ,]H
MO^_1_P#BJ-MS_P ]HO\ OT?_ (J@":BH=MS_ ,]HO^_1_P#BJ-MS_P ]HO\
MOT?_ (J@":BH=MS_ ,]HO^_1_P#BJ-MS_P ]HO\ OT?_ (J@":BH=MS_ ,]H
MO^_1_P#BJ-MS_P ]HO\ OT?_ (J@":BH=MS_ ,]HO^_1_P#BJ-MS_P ]HO\
MOT?_ (J@":BH=MS_ ,]HO^_1_P#BJ-MS_P ]HO\ OT?_ (J@":BH=MS_ ,]H
MO^_1_P#BJ-MS_P ]HO\ OT?_ (J@":BH=MS_ ,]HO^_1_P#BJ-MS_P ]HO\
MOT?_ (J@":BH=MS_ ,]HO^_1_P#BJ-MS_P ]HO\ OT?_ (J@":BH=MS_ ,]H
MO^_1_P#BJ-MS_P ]HO\ OT?_ (J@":BH=MS_ ,]HO^_1_P#BJ-MS_P ]HO\
MOT?_ (J@":BH=MS_ ,]HO^_1_P#BJ-MS_P ]HO\ OT?_ (J@":BH=MS_ ,]H
MO^_1_P#BJ-MS_P ]HO\ OT?_ (J@":BH=MS_ ,]HO^_1_P#BJ-MS_P ]HO\
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M/+'*UEA'N5(DB 49"LX<\Q''IFVY_P">T7_?H_\ Q5&VY_Y[1?\ ?H__ !5
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MX(_Z'+P__P"#2#_XJ@#I*A;_ (_HO^N;_P UK!_X6/X(_P"AR\/_ /@T@_\
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MR/>6JA(&72[^[N+F:$LK$S^9<?O-DG"JO0>2<A)#+&@!UFVY_P">T7_?H_\
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MAX@F,>K>!PMM>3!-2,DCV]I+,D2FSGB#.R*0@WS1C+$=2>BL1U.VY_Y[1?\
M?H__ !516JW'V.';+$!Y:X!C)[?[U 'DWA_2].MO[$*Z'K#O>^(-2M[Z2^TR
M\E>2PD^T^7',TJ$^0S36SD,=I<L[?,LA%&Q\+6DW@OPA!J&B:IH^E6^GNNH1
M6^@QW#SZAY=L!*]JT$K9^2X7S6C!^4X;;(I?VS;<_P#/:+_OT?\ XJC;<_\
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M/_/:+_OT?_BJ /)M1T'3HK71K?3M&U2?4X=/O1'J6J:/YFRR82G[.P2W=$+
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MS_SVB_[]'_XJ@":BH=MS_P ]HO\ OT?_ (JC;<_\]HO^_1_^*H FHJ';<_\
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M:+_OT?\ XJ@":BH=MS_SVB_[]'_XJC;<_P#/:+_OT?\ XJ@":N)M]:75OB#
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M;+;_ )^(O^^Q1]LMO^?B+_OL4 345#]LMO\ GXB_[[%'VRV_Y^(O^^Q0!@^
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M[CO.20  [6YHI?(\J1'QNSM8''2@#5L_^/&#_KFO\JFJ&S_X\8/^N:_RJ:@
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M-AO^4-DQEMK7OB+'(UWX7\F/6+CS=3D@DM-)U)[22X0VD\F,B6-3AHD;+,"
MI ^\00#L-MS_ ,]HO^_1_P#BJ-MS_P ]HO\ OT?_ (JO.-6L9;7X5V=]'_PD
MD%Q?:AIETVGOK-Q]IMS-+;Q26JRNZ/@AG&'8 .Q/RX&W7\,1R?VKJND7D>L:
M9:7-E&]O8ZIJ3S71.Z19YHYUED(7#0+A9<HPR53>K. =AMN?^>T7_?H__%4;
M;G_GM%_WZ/\ \57E3Z,TOP(3Q-)K?B ZC'X26YC9=:NE59Q \QE(5QO8N_.[
M< $10 !@[?BGPM!I&B^;8ZMX@1;G4]+A9&UR[;8&O%B?:YDWC>D[*PW8^5"
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M>.VA^V7<MTS7*;C<,DDC,Q3YHH\;L+)#*-H()8 E^P^-_P#H8?#_ /X(9_\
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M&2%H(M1N5@\VV0\XC58UC'S ,24)8JN[<$4#5^QVW_/O%_WP*/L=M_S[Q?\
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M]:T?L=M_S[Q?]\"LO5?#UCJMU;I.U[;JB2$"PU">SW'*_>\EUW8[9SC)QU-
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;ZS-7\':?:^3Y%_X@3=NS_P 5%?G/3UFH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_11a.jpg
<TEXT>
begin 644 image_11a.jpg
MB5!.1PT*&@H    -24A$4@   F8   )@" (   "O%SC      7-21T( KLX<
MZ0  7+!)1$%4>%[MG0&VG+BN:%_^=#KSNF.Z\SIW//VKCQ*U(ME&V& ,[+.R
MLBB096G;92%1P(^___[[_[[__O>___WUUU^RS1\$( "!0PCD%Y:\Y"&&/4E)
M'EU>\DE\#O%%T/V_0W2A! (0@  $(/!X C^^OKX>[R0.0@ "$(  !,8)_* P
M.PX1#1" 0(U OA*8EX2V(Y!'EY<$<A$RA5DF!@0@  $(0"!%@)"9PH00!"
M 0A @)#)'(  !"   0BD"+2N9?[G/_\1'?_][W]3RKJ$I)=3N_CH5U^<1W-Z
M5S"U[N+^\PQSFC\?-^$WC*F![9H+A4;G<3C*0O2T">0OGN4E8>X(Y-'E)8%<
MA'Q]EOE9KS>7[,'!<\MZC*"#^N_5W */9';Y,@'LA.FQRV6$(0"!-Q.H9IEZ
M=A^3$DD*G4#,%(M):E1;2["<0KLZ:XC=M$&&MN:"/=2PMI:8%M46,^8:S$;V
MF<3BPG^-C#TIB="L@VW.[JO2 &O)%X<R3J%H?!P[ZZ\[TZH518H>O?D[/]GW
M?%J3EYSLPOK=Y='E)=?W>K*%0X\RT&7(KD>9;;>21I^+2EPVT_B829MBXC+8
MJ8M;-?,RMM4F09+M8-=MSIL3U(&MV;PY!QH=93@T^AT9@DWW$8  !!Y/H+,P
M:Q?'6@22_9(*Q*6J6'#3K,4E$*JJ5L+-E.\^RO4OCFO4D._4FNW\K:4^Q8E5
MLS J<3P;IKK4S?:KA]3W39?S9C>8J)+,J-D>:]-CLZ\^OQ[_Y<=!"$!@+X%R
MR-0UZ*.N%O,V>VK'I\WFQ4A<S!)J<=0NS:Z[&'(:Z5VRTTU_-^UL,Y'F126U
MKAM-VIE<,AN+QL0\56PKGJ.X 1(Q._<:1M:F1[&OQM!LSD,$(  !""B!5I:Y
MU$*37$EK0]N79PQVNG>>=1CI@E8RU+7C92TP%UMUV+P7RXC\X7Q&C*$M!"!P
M=P*=A=F,VW8Q[4BP;'8R&+IJB4[;B[V=-ORU^5,&75&FID3[C:WV]KO7Y4VP
M^3E@BQF9V1*[KO75X-,]%C2$  3>2: 0,MV5(:V Y3,87?XT3TVVM0V+ 2"I
MIQ9R-I?XODX;_NKJ/V)Y5&+WM(L!VF\C#CDL>RD5#>B> ^UB[.=H,5CJ?F?,
MWAGXSE4 KR$ @22!L[),MT!G\@:QV$KJ=MRY*P+%WC/V[.JTX6_1B^3PJ%@1
MB\/5^%CS=]/L-N<VV.XYL!DU&U/%'3K#AKUCASP$(/ 8 KS)Y#%#^8<C>TNL
MSZ2 5PL0R-\(F)=<P*VU3,BCRTNNY>$"U@S=E[F _9@  0A   (0F$K@K,+L
M5"?H# (0@  $(' ^@1]?7U_G]T(/$(  !"  @=L3X%KF[8<0!R"P,H'\Q;.\
MY,K^7F);'EU>\A)'5NZ4:YDKCPZV00 "$(# <@2XEKG<D& 0!"   0BL28"0
MN>:X8!4$(  !""Q'H!HR[6-3W/WLR<<(),5.1=)GP^;S="Y\IHSU:.]C>DY%
MC7((0  "CR?0>I.)=5Y7ZF002HJ=RK?/!ON\P&A>U-G72Y_CKB]]EF&?-EI!
M  (0@, N N5?S+IGQ^C'N&1_.K,[[<.UU8[&(U*U^4<F]N*>=E9\7&JM5=%4
MAR8J;+=JR%O'K2^;/18))*G&1_SL0B2VQ>';-8$0AD";0/XGFGE)F#L">71Y
M22 7(:>N93:RF7S-UE44:[&D)I9L[F) 8]3;"AL-:X][U2:UC+S;A60BVZ$_
M/WQ\?R   0A (/6^S)B[:!"5#1=3[8/(7?JEDHT:8XS0MEA:3&0_ [EI@QWL
M6KX8+>^;(C&QWN5"DFK&(RM3._4I=M?G.*T@  $(/)A .63&-U2T$YW/T4PF
M)&(9R2+Q1O-H<&;,I%5?V\TTM*AVEPL=K!H>-=P<')<,:F0@  $(/(! -<O,
M9QZ:/ST QSHNS*%:NUJ\#@<L@0 $(+ .@>HO9I.YX*Z5W8;ACMQNL'F$+L8G
M/=7F[4N&JK"H-NG"+JJQ/+O+HUA77V=V8@D$( "!I0BDKF46@XV+',5E6DN+
M>@%2:X![EW4)11W-B^7->*TQ$\)M*ZNV4<>V%T?WNE KS![H40?/I:8OQD
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M=K^M9VIATPE("-3@9#>BY*;_MD?57"R<UNR7+M2D^+'61<V%:$;$XG3:T-Z
MX%RP-K>]V\1XH  A\T"8J(( !""PF\#MBI.[/7Q0 T+F@P835R  @5L1<,7)
MPVVO%7(/[^@]"GG%]'O&&D\A  $(0&"( *^8'L)'8PA H$T@_^+HO"3,'8$\
MNKPDD(N0*<PR,2   0A   (I H3,%":$(  !"$   H1,Y@ $(  !"$ @18"0
MF<*$$ 0@  $(0("0R1R   0@  $(I @0,E.8$(( !"   0@0,ID#$(  !"
M@10!0F8*$T(0@  $(  !0B9S  (0@  $() B0,A,84(( A"   0@0,AD#D
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M2P+9$> 5TTP)"$   A" P X"IU_+W&$+HA"   0@ (&%"1 R%QX<3(, !"
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M!P$(0  "$+B6 "'S6O[T#@$(0  "MR% R+S-4&$H!"   0A<2Z :,O4&6_?
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M$#B<0'YAR4L>;N3=%>;1Y27OSN1P^P7=$ZYE'HX&A1"   0@ (%(@)#)K(
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M"00@  $(G$J D'DJ7I1#  (0@,!S"! RGS.6> (!"$   J<2(&2>BA?E$(
M!"#P' *$S.>,)9Y   (0@,"I! B9I^)%.00@  $(/(< (?,Y8XDG$(  !"!P
M*@%"YJEX40X!"$   L\A0,A\SECB"00@  $(G$J D'DJ7I1#  (0@,!S"! R
MGS.6> (!"$   J<2(&2>BA?E$(  !"#P' *$S.>,)9Y   (0@,"I! B9I^)%
M.00@  $(/(? C_R+UI[C-)Y   (0@  $]A/XH>_RSK\\?7\OM(  !%Y*(+^P
MY"5?BK+N=AY=7A+(CH"@HS#+Q(  !"   0BD"! R4Y@0@@ $(  !"! RF0,0
M@  $( "!%(%"R/P1_E*:_A3ZZ.AHY9J($C&G0UM?JXZ.KFK23>8J@^D7 A"
MP*T)%$*F_"#H\[_\];G7W5"[^\0#M:3;AF='S7'(?6!I!0$(0."=!+8+LZS+
M[YP9> T!"$   H[ 1LBT69HM ^JV%G&E@BK:W5%[2(\6-<04TYEKN[-]N:[U
MXR?>NT0SVN9L=O9; USOQ8^.0P2B>ZRS-;9QOD8"1;S%?ETA]]DI.%]U"$
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M$'XO4_7\$]B^'X7V3_R3C<__&CL_V_+/Q3\1MH?BGMCJN]/1D,F800 "$(!
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MQ/'4-Y <'CC_-/JPD!ES.$W"-#+)C&F7)F(8BY1W%3=V">\:T?,T[S(#80A
MX!8$N'HU8Y@JUR"S75=>8*+-#PB9-@FS<T(O;FNDE*/'GFJI3@)8=DX@!P$(
M0  "D<!6O/RT."!DULB[G#*38G8,HJOW=FB@"00@ ('S"!R;))QGY[TUC]=C
M[8]OZRQ&0Z;,!IT3\:.$-#% 4DQ;>M6DTVZHL&VES5UWFF6Z>>GVUSJRB6_1
M"[UN:HTO>GWO"8?U$(# .03<[2*?3NSJ%*];R5*C2V51^!Q+[Z;5UF#=[2+?
ME'_=>6ES1XFL\9#>:N+NU R_I!T-F5)]M5%0/S8.Z<BHC-V0*24ZBP+VD&:9
M\3I!K6W-,*O6=NVVBX?N-M>P%P(0F$= UY:X]-D]LNT6J.*>>:;?J">]+],P
M_77SI=WSF_(?A_0V3?T94<7QT9!Y(YZ8"@$(0. J II77&7 ,_MU/_9)WUZY
M3:-R7?/V(9.JQ?;8(P$!"$#@J00.#),6444MKYA^ZCS"+P@L08!73,\9AF06
MRV^11H;CGPPM_V[2D9YH"P$(0*!-X*^__@)1-X'/J4FF+9 SE&HR'\ADF2,
M:0L!"&P0(,N<,T7(,B=P_D"^_;7,"9CH @(0F$#@4_':_)4[ D4"^6(AD+NG
MD$ F9$Y8"N@" A"   2>0("0^811Q <(0  "$)A @) Y 3)=0  "$(# $P@0
M,I\PBO@  0A   (3"! R)T"F"PA   (0> (!0N831A$?(  !"$!@ @%"Y@3(
M= $!"$   D\@0,A\PBCB P0@  $(3"! R)P F2X@  $(0. )! B93QA%?(
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M8I]>B=1 I?(Q;KD>U9)=JHK15#7;>.DLUUXDEXV^G$5\HEY"YD38= 4!"+R
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M(  !"$#@5 (\RN!4O"B'P-L)Y.^=STN^G6GP/X\N+PED1X!'&3 E(  !"$
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M@!9:.ZP\K^*JRW&CBXQ,AU/C38I5;JLV7J3L[O2,(<B S<A$IPB9W0--0PA
MX#("LL[&U=;NMX59K2Z*@![2"YQ6FU4K#>5/*XVN]UBZ5 %5I3VZE=JUK?EU
M*FAKK?/4@6I_C%C$;''986P/@3:<!C]:6&1.R#QU*J(< A XA8"KZ=GK9W)(
M>E4QNV$/.3%MHD;'AE:M-G=.NGYC+]&VHLPI[(+22,F*6)XU/@V,VCR688LC
M%;LN&F"'>"9\0N:<.4DO$(# 8PG8!/2Q3J[JV&3XA,Q5)P)V00 "-R&@&<]-
M['V4F9/A\XKI1\T>G(' ?0G\_/GSOL9?;OG7UU?&!B!G*-5D/I!YQ?0(0-I"
M  (;!/+O-,Y+ MT1R*/+2P*Y")G"+!,# A"   0@D") R$QA0@@"$(  !"!
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MRBZ%(IR)D9LT&PEBOI=-XS?3T$T[5<!:M=EO7JV<<W10'1G'7>8A# $(/)B
MG+)KN-GTM)V5;C;O$RB$3'=N53.KG52UK2E&V0Z%3D\R>(N#^7";4=MA?-^
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M@X0[)'<3RI_>-5=K?FO:FRC4N\A$XJ5]^$!11D]!-I$VFCO(O&+ZUK,.XR$
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MGDN 5TP_=VSQ# (+$,B_TS@ON8!;:YF01Y>77,O#!:P1=!1F%Q@*3(  !"
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MMLVG6@V9>FZE/F@6Z*S4&&;/PAK-9?;HJ9RKQ.HT%6UV=FKXC(?V@D8> A"
M0#<!7>MJJV);<Z-Y5-C71;=K5S74I%.7_08E%7;APX:&DR#O>\5T+);*'J%L
M3QR*9=6&0%NS*K>]7#6T] L!"+R$0$PH]9S>YA)V&;1D;//&MFM>6PS;V>U]
M1R1F\QI0:I ;B&P\:HQ1-^3+"K/W'6 LAP $7DY@L!XXV/PE\ <I#3:O029D
MOF3ZX28$(' 8@<&$;[#Y86ZLK6B0TF#S&AM>,;WVK,$Z"$   A!8A@"OF%YF
M*# $ D\DD'^G<5[RB9R&?,JCRTL.&?3$QKQB^HFCBD\0@  $(' : :YEGH86
MQ1"   0@\"P"A,QGC2?>0  "$(# :00(F:>A13$$(  !"#R+ "'S6>.)-Q"
M  0@<!H!0N9I:%$, 0A   +/(D#(?-9XX@T$(  !")Q&@)!Y&EH40P "$(#
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M79(-6YAU9T]Z:+.M0V;5ZJG9IK8:,M?0?13B#2^LORJY&9ZOFGST"P$('$7
MYH6B4[-&NV3I*;L>S:\/NF;J$N2R51'0H-O1Q5$T3M(S"#D"B21/@ES^Q:RK
MA=J/6NJTITY%>0U+KHE$(%LRC?J+/;J&3DD<6MN%MG5B-2]<VY/F#6HA ('5
M"+@UP2X[&A1M=&PL1#&(:A14KV/SS)[5H.VU9Q!RD7D,*V= [KR6N1?0W>7G
MI_]W)X;]$'@P@<$%8;#Y@\%:UP8I#3:O07Y=R-2"0'+:V0I)L@EB$(# LPGD
M:[!%#H/-G\W6IH8CGIX$F5=,CPP*;2$  0A X$4$>,7TBP8;5R$PGT#^G<9Y
FR?E>+-YC'EU><G&7YYLGZ/X_1.3R,VI5GV\     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
